Aside from providing protection for the active ingredient, these patents also disclose that semaglutide can be used to treat various indications, including diabetes, obesity and cognitive disorders, as well as in combination with other drugs
This means patients using GLP-1s for other medical reasons, such as weight management without a Type 2 Diabetes diagnosis , may no longer have coverage
445 adults with obesity and symptomatic knee osteoarthritis taking 12 mg lost an average of 28.7% of body weight over 68 weeks
you're building a new foundation for your health, and we're here to help you lay every stone correctly
W., Astrup, A., Hjorth, M
If you need to shift your injection day, move it by one day at a time over several weeks rather than making a sudden change